Effect of co-solvents on the controlled release of calcitonin polypeptide from in situ biodegradable polymer implants

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 12, Issue 6, 2005, Pages 393-398

  Prabhu, Sunil ^a   Tran, Lan P ^a   Betageri, Guru V ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Benzyl Alcohol; Benzyl Benzoate; Calcitonin; Co Solvent Combinations; DSC; In Situ Implants; In Vitro Release Kinetics; Stability

Indexed keywords

BENZYL ALCOHOL; BENZYL BENZOATE; CALCITONIN; PHOSPHATE BUFFERED SALINE; POLYLACTIC ACID; POLYPEPTIDE;

ARTICLE; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; IMPLANT; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ABSORBABLE IMPLANTS; BENZOATES; BENZYL ALCOHOL; CALCITONIN; DRUG DESIGN; DRUG IMPLANTS; DRUG STABILITY; LACTIC ACID; POLYMERS; SOLUBILITY; SOLVENTS; TEMPERATURE; TIME FACTORS;

EID: 27644484661     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540590968873     Document Type: Article

References (23)

1. Bleiberg, B., Beers, T. R., Persson, M., and Miles, J. 1993. Metabolism of triacetin-derived acetate in dogs. Am. J. Clin. Nutr. 58:908-911.
2. Chandrashekhar, G., and Udupa, N. 1996. Biodegradable injectable implants for long term drug delivery using poly (lactic-co-glycolic) acid copolymers. J. Pharm. Pharmacol. 48:669-674.
3. Chern, R. T., and Zingermann, J. R. 1999. Liquid polymeric compositions for controlled release of bioactive substances. WO Publications Number 9947073.
4. Cherng-Chyi Fu, R., Lidgate, D. M., Whatley, J. L., and McCullough, T. 1998. The biocompatibility of parenteral vehicles in vivo/in vitro screening comparison and effect of excipients on hemolysis. J. Parent. Sci. Technol. 41(5):164-168.
5. Cleland, J. L. 2001. Injectable gels for local and systemic delivery of proteins. Abstract #0221. Controlled Release Society Annual meeting. San Diego, CA.
6. Crowther, M. A., Pilling, A., and Owen, K. 1997. The evaluation of glycofurols as a vehicle for use in toxicity studies. Hum. Exp. Toxicol. 16:406.
7. Davis, S. S., and Ilum, L. 1988. Polymeric microspheres as drug carriers. Biomaterials 9:111-115.
8. Dunn, R. L., English, J. P., Cowsar, D. R., and Vanderbelt, D. D. 1994. Biodegradable in situ forming implants and methods of producing the same. U.S. Patent 5 278 201 11.
9. Dunn, R. L., Tipton, A. J., Southard, G. L., and Rogers, J. A. 1997. Biodegradable polymer composition. U. S. Patent 5 599 552.
10. Eastell, R. 1998. Treatment of menopausal osteoporosis. N. Eng. J. Med. 338:736.
11. Eliaz, R. E., and Kost, J. 2000. Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins. J. Biomed. Mat. Res. 50:388-396.
12. Eliaz, R. E., Wallach, D., and Kost, J. 2000. Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants: in vivo. Pharm. Res. 17(12):1546-1550.
13. Graham, D., Brodbeck, K. J., and McHugh, A. J. 1999. Phase inversion dynamics of PLGA solutions related to drug delivery. J. Contra. Rel. 58:233-245.
14. ICH Topic Q3C (M). 2000. Maintenance of note for guidance on impurities: residual solvents (CPMP, ICH/283/95). European Agency for the Evaluation of Medical Products, London, UK.
15. Jain, R. A., Rhodes, C. T., Railkar, A. M., Malick, A. W., and Shah, N. A. 2000. Controlled release of drugs from injectable in-situ formed biodegradable PLGA microspheres: effect of formulation variables. Eur. J. Pharm. Biopharm. 50:257-262.
16. Jain, R. A. 2000. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21:2475-2490.
17. Kranz, H., Brazeau, G. A., Napaporn, J., Martin, R. L., Millard, W., and Bodmeier, R. 2001. Myotoxicity studies of injectable biodegradable in-situ forming drug delivery system. Int. J. Pharm. 212:11-18.
18. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with folin phenol agent. J. Biol. Chem. 193:265.
19. Matschke, C., Isele, U., Hoogevest, P. V., and Fahr, A. 2002. Sustained release injectables formed in-situ and their potential use for veterinary products. J. Control. Rel. 85:1-15.
20. Moltu, F., Laurent, A., Rufenacht, D. A., and Doelker, E. 2000. Organic solvent for pharmaceutical parenterals and embolic liquids: a review of toxicity data. J. Parent. Sci. Technol. 54(6):457-469.
21. Royals, M. A., Fujuta, S. M., Yewey, G. L., Rodriguez, J., Schultheiss, P. C., and Dunn, R. L. 1999. Biocompatibility of a biodegradable in-situ forming implant system in rhesus monkeys. J. Biomed. Mater. Res. 45:231-239.
22. Singh, U. V., Udupa, N., Kamath, R., and Umadevi, P. 1997. Enhanced antitumor efficacy of methotrexate poly (lactide-co-glycolide) acid injectable gel implants in mice bearing sarcoma-180. Pharm. Sci. 3:133-136.
23. Yolles, S., Eldridge, J. E., and Woodland, J. H. R. 1971. Sustained delivery of drugs from polymer drug mixtures. Polymer News 1:9-12.